SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-24-029871
Filing Date
2024-08-01
Accepted
2024-08-01 08:38:30
Documents
17
Period of Report
2024-08-01
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 37895
2 ex5-1.htm EX-5.1 20115
3 ex5-1_001.jpg GRAPHIC 5940
4 ex5-1_002.jpg GRAPHIC 3757
5 ex5-1_003.jpg GRAPHIC 1413
  Complete submission text file 0001493152-24-029871.txt   249891

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE imnn-20240801.xsd EX-101.SCH 3009
7 XBRL LABEL FILE imnn-20240801_lab.xml EX-101.LAB 34240
8 XBRL PRESENTATION FILE imnn-20240801_pre.xml EX-101.PRE 22355
19 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3688
Mailing Address 997 LENOX DRIVE SUITE 100 LAWRENCEVILLE NJ 08648
Business Address 997 LENOX DRIVE SUITE 100 LAWRENCEVILLE NJ 08648 (609) 896-9100
Imunon, Inc. (Filer) CIK: 0000749647 (see all company filings)

IRS No.: 521256615 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-15911 | Film No.: 241164577
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)